3.09 USD
▼-0.10-3.13%
盘后 3.15 +1.94%
2026-09-15
市值
$187.93M
市盈率
—
EPS
-1.81
股息率
—
52 周区间
2.94 – 5.55
成交量
451.95K
Beta
1.32
目标价
14.89
52W 低 2.9452W 高 5.55
价格走势
公司简介
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small mo...